PLSE
Income statement / Annual
Last year (2024), Pulse Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Pulse Biosciences, Inc.'s net income was -$53.59 M.
See Pulse Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$700.00 K |
$1.42 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$1.21 M
|
$11.94 M
|
$1.97 M
|
$1.10 M
|
$666.00 K
|
$665.00 K
|
$665.00 K
|
$665.00 K
|
$0.00
|
| Gross Profit |
$0.00
|
-$1.21 M
|
-$11.24 M
|
-$550.00 K
|
-$1.10 M
|
-$666.00 K
|
-$665.00 K
|
-$665.00 K
|
-$665.00 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
-16.06
|
-0.39
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$32.34 M
|
$27.80 M
|
$20.84 M
|
$28.64 M
|
$26.44 M
|
$24.96 M
|
$17.25 M
|
$9.65 M
|
$5.99 M
|
$2.58 M
|
| General & Administrative Expenses |
$23.92 M
|
$15.78 M
|
$13.96 M
|
$19.07 M
|
$22.86 M
|
$22.33 M
|
$20.05 M
|
$15.50 M
|
$2.93 M
|
$1.22 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$12.02 M
|
$14.75 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$23.92 M
|
$15.78 M
|
$25.97 M
|
$33.82 M
|
$22.86 M
|
$22.33 M
|
$20.05 M
|
$15.50 M
|
$2.93 M
|
$1.22 M
|
| Other Expenses |
$0.00
|
-$1.21 M
|
$0.00
|
$0.00
|
-$430.00 K
|
$666.00 K
|
-$28.00 K
|
$665.00 K
|
$665.00 K
|
$665.39 K
|
| Operating Expenses |
$56.26 M
|
$42.37 M
|
$46.81 M
|
$62.46 M
|
$48.87 M
|
$47.95 M
|
$37.96 M
|
$25.81 M
|
$9.59 M
|
$4.47 M
|
| Cost And Expenses |
$56.26 M
|
$43.57 M
|
$58.76 M
|
$64.43 M
|
$49.97 M
|
$47.95 M
|
$37.96 M
|
$25.81 M
|
$9.59 M
|
$4.47 M
|
| Interest Income |
$2.67 M
|
$2.46 M
|
$0.00
|
$0.00
|
$114.00 K
|
$983.00 K
|
$446.00 K
|
$247.00 K
|
$68.00 K
|
$0.00
|
| Interest Expense |
$0.00
|
$1.10 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.18 M
|
$1.21 M
|
$1.36 M
|
$1.15 M
|
$1.10 M
|
$1.16 M
|
$1.31 M
|
$1.00 M
|
$759.00 K
|
$716.98 K
|
| EBITDA |
-$55.08 M |
-$42.37 M |
-$56.70 M |
-$61.87 M |
-$48.87 M |
-$46.79 M |
-$36.65 M |
-$24.57 M |
-$8.83 M |
-$3.75 M |
| EBITDA Ratio |
0
|
0
|
-81
|
-43.63
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
-82.94
|
-44.44
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.67 M
|
$1.36 M
|
-$448.00 K
|
-$646.00 K
|
$114.00 K
|
$983.00 K
|
$418.00 K
|
$247.00 K
|
$68.00 K
|
$0.00
|
| Income Before Tax |
-$53.59 M
|
-$42.21 M
|
-$58.51 M
|
-$63.66 M
|
-$49.85 M
|
-$46.97 M
|
-$37.55 M
|
-$25.57 M
|
-$9.52 M
|
-$4.47 M
|
| Income Before Tax Ratio |
0
|
0
|
-83.58
|
-44.89
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$28.00 K
|
$0.00
|
-$94.00 K
|
-$1.66 M
|
| Net Income |
-$53.59 M
|
-$42.21 M
|
-$58.51 M
|
-$63.66 M
|
-$49.74 M
|
-$45.99 M
|
-$37.55 M
|
-$25.57 M
|
-$9.52 M
|
-$2.81 M
|
| Net Income Ratio |
0
|
0
|
-83.58
|
-44.89
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.92 |
-0.88 |
-1.72 |
-2.28 |
-2.14 |
-2.22 |
-2.2 |
-1.73 |
-0.86 |
-0.37 |
| EPS Diluted |
-0.92 |
-0.88 |
-1.72 |
-2.28 |
-2.14 |
-2.22 |
-2.2 |
-1.73 |
-0.86 |
-0.37 |
| Weighted Average Shares Out |
$58.40 M
|
$48.04 M
|
$33.94 M
|
$27.96 M
|
$23.25 M
|
$20.75 M
|
$17.08 M
|
$14.75 M
|
$11.01 M
|
$7.57 M
|
| Weighted Average Shares Out Diluted |
$58.40 M
|
$48.04 M
|
$33.94 M
|
$27.96 M
|
$23.25 M
|
$20.75 M
|
$17.08 M
|
$14.75 M
|
$11.01 M
|
$7.57 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
